CirTran Valuation
| CIRX Stock | USD 0.03 0 3.85% |
CirTran seems to be undervalued based on Macroaxis valuation methodology. Our model approximates the value of CirTran from analyzing the firm fundamentals such as Operating Margin of (0.18) %, return on asset of -0.16, and Shares Outstanding of 4.95 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that CirTran's price fluctuation is out of control at this time. Calculation of the real value of CirTran is based on 3 months time horizon. Increasing CirTran's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CirTran is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CirTran Pink Sheet. However, CirTran's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.027 | Real 0.0285 | Hype 0.03 | Naive 0.0228 |
The intrinsic value of CirTran's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CirTran's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CirTran helps investors to forecast how CirTran pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CirTran more accurately as focusing exclusively on CirTran's fundamentals will not take into account other important factors: CirTran Total Value Analysis
CirTran is currently projected to have valuation of 3.26 M with market capitalization of 128.58 K, debt of 2.53 M, and cash on hands of 6.85 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CirTran fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.26 M | 128.58 K | 2.53 M | 6.85 K |
CirTran Investor Information
The company last dividend was issued on the 20th of September 2019. CirTran had 1:1000 split on the 20th of September 2019. Based on the analysis of CirTran's profitability, liquidity, and operating efficiency, CirTran is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.CirTran Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CirTran has an asset utilization ratio of 199.76 percent. This suggests that the Company is making $2.0 for each dollar of assets. An increasing asset utilization means that CirTran is more efficient with each dollar of assets it utilizes for everyday operations.CirTran Ownership Allocation
CirTran shows 4.8 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities.CirTran Profitability Analysis
The company reported the previous year's revenue of 2.92 M. Net Loss for the year was (838.47 K) with profit before overhead, payroll, taxes, and interest of 1.9 M.About CirTran Valuation
Our relative valuation model uses a comparative analysis of CirTran. We calculate exposure to CirTran's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CirTran's related companies.CirTran Corporation provides manufacturing, marketing, distribution, and technology services for consumer products, including tobacco products, medical devices, and beverages worldwide. The company was incorporated in 1987 and is based in Las Vegas, Nevada. CIRTRAN CORP operates under Conglomerates classification in the United States and is traded on OTC Exchange. It employs 3 people.
8 Steps to conduct CirTran's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CirTran's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CirTran's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CirTran's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CirTran's revenue streams: Identify CirTran's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CirTran's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CirTran's growth potential: Evaluate CirTran's management, business model, and growth potential.
- Determine CirTran's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CirTran's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
CirTran Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 144.3 M | |
| Retained Earnings | -77.8 M |
Additional Tools for CirTran Pink Sheet Analysis
When running CirTran's price analysis, check to measure CirTran's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CirTran is operating at the current time. Most of CirTran's value examination focuses on studying past and present price action to predict the probability of CirTran's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CirTran's price. Additionally, you may evaluate how the addition of CirTran to your portfolios can decrease your overall portfolio volatility.